Evidence map›Paper›PMID 26805445›Full record

ArticleIntegrative biology : quantitative biosciences from nano to macro2016

Microfluidic device for simultaneous analysis of neutrophil extracellular traps and production of reactive oxygen species.

S F Moussavi-Harami, K M Mladinich, E K Sackmann, M A Shelef, T W Starnes, D J Guckenberger, A Huttenlocher, D J Beebe

Open access · hybridAbstract read
In one paragraph

Article in Integrative biology : quantitative biosciences from nano to macro, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Tissue Models forFrontiers in cellular and infection microbiology · 2022
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Microfluidic devices for neutrophil chemotaxis studies.Journal of translational medicine · 2020
    Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

S F Moussavi-HaramiMedical Scientist Training Program, University of Wisconsin, Madison, WI, USA.
K M Mladinich
E K Sackmann
M A Shelef
T W Starnes
D J Guckenberger
A Huttenlocher
D J Beebe
Madison Group (United States) · USUniversity of Wisconsin–Madison · US

Funding

UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI AMY TRENTHAM-DIETZ · 1985 to 2026
$142.6M
Institutional Clinical and Translational Science AwardUL1TR000427 · NCATS · UNIVERSITY OF WISCONSIN-MADISON · PI DREZNER, MARC KENNETH · 2012 to 2016
$32.2M
GRADUATE TRAINING IN MOLECULAR BIOSCIENCEST32GM007215 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI HULL, CHRISTINA M · 1985 to 2018
$22.5M
INTEGRATED TRAINING FOR PHYSICIAN-SCIENTISTST32GM008692 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI BURKARD, MARK E · 1998 to 2020
$10.3M
RESEARCH TRAINING IN HEMATOLOGYT32HL007899 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI Jane Ellen Churpek · 1998 to 2026
$8.2M
Understanding cell migration through microscale in vitro modelsR01EB010039 · NIBIB · UNIVERSITY OF WISCONSIN-MADISON · PI BEEBE, DAVID J, HUTTENLOCHER, ANNA · 2011 to 2014
$1.7M
Reactive Oxygen Species in the Resolution of InflammationF30HL114143 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI STARNES, TAYLOR W · 2012 to 2014
$123k
NCATS NIH HHS UL1 TR000427NCI NIH HHS P30 CA014520NHLBI NIH HHS F30 HL114143NHLBI NIH HHS T32 HL007899NIBIB NIH HHS R01 EB010039NIGMS NIH HHS T32 GM007215NIGMS NIH HHS T32 GM008692
6 · The paper itself

Abstract

Neutrophil extracellular traps (NETs) were first reported in 2004, and since their discovery, there has been an increasing interest in NETs, how they are formed, their role in controlling infections, and their contribution to disease pathogenesis. Despite this rapid expansion of our understanding of NETs, many details remain unclear including the role of reactive oxygen species (ROS) in the formation of NETs. Further, to study NETs, investigators typically require a large number of cells purified via a lengthy purification regimen. Here, we report a microfluidic device used to quantify both ROS and NET production over time in response to various stimulants, including live bacteria. This device enables ROS and NET analysis using a process that purifies primary human neutrophils in less than 10 minutes and requires only a few microliters of whole blood. Using this device we demonstrate the ability to identify distinct capabilities of neutrophil subsets (including ROS production and NET formation), the ability to use different stimulants/inhibitors, and the ability to effectively use samples stored for up to 8 hours. This device permits the study of ROS and NETs in a user-friendly format and has potential for widespread applications in the study of human disease.

Indexed as

Extracellular TrapsLab-On-A-Chip DevicesBenzimidazolesChromatinDimethylpolysiloxanesEquipment DesignFluorescent DyesHEK293 CellsHumansMicrofluidicsNADPH OxidasesNeutrophilsOnium CompoundsPseudomonas aeruginosaReactive Oxygen SpeciesbaysilonBenzimidazolesbisbenzimide ethoxide trihydrochlorideChromatinCYBA protein, humanDimethylpolysiloxanesdiphenyleneiodoniumFluorescent DyesNADPH OxidasesOnium CompoundsReactive Oxygen Species

Identifiers

PMID26805445
PMCPMC4776335
OpenAlexW2253631414

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.